Fournier Gangrene Associated With Sodium–Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases -

Fournier Gangrene Associated With Sodium–Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases
Information type: Other primary research
Source: Annals of Internal Medicine
Specialities: Diabetes | Infection and infectious diseases | Renal and urologic disorders
Summary
Review describes 55 cases of Fournier Gangrene reported to the FDA, in patients receiving SGLT2 inhibitors between 1 Mar 2013-31 Jan 2019. Physicians prescribing these agents should be aware of this complication and have a high index of suspicion to recognize it in early stages.
UKMi comment
The report is limited by failure to establish causality or incidence, based on the variable quality of the reports.
Related links: